Policy and Legislation
The vaccines from Pfizer-BioNTech and Moderna will be available later this week, CDC says.
The number of hospitalizations and deaths in the United States continues to rise.
Facilities and insurers would be compelled to list the prices they charge patients and PBMs to disclose rebates and discounts.
Healthcare is a growing sector of the economy including the export of pharmaceuticals, medical equipment and devices, says Filipe Santos Costa, chairman and CEO of AICEP.
CMS estimates about 75% of nursing homes would have to strengthen staffing in their facilities under the proposal.
CMS believes that eligibility systems in a number of states are programmed incorrectly, possibly leading to disenrollments.
The group urged CMS to consider other coverage gaps that subject patients to unaffordable cost sharing and address them in its rulemaking.
Negotiations with participating drug companies will occur in 2023 and 2024, and prices will become effective beginning in 2026.
With the expiration of the public health emergency ending waivers and flexibilities, providers are looking for answers, says Dr. Robert Murry, chief medical officer of NextGen Healthcare.
The company has now removed prior authorization on more than 1,100 medical services since 2020.